Skip to main content
rants_case-study-background-scaled-1

Our Grants

GRANT DATE AMOUNT PROGRAM
Johns Hopkins University
Novel Anti-Fibrotics for Fibrostenotic Crohn's Disease
06.24.2026 $2,872,156.00 Crohn's Disease, Therapeutics
The Weizmann Institute of Science
Utilizing IPHOMED (Integrated Proteo-genomics of HOst-MicrobiomE-Diet) to decode biomarkers & nutritional cues in CD
03.24.2026 $1,398,658.00 Crohn's Disease, Prevention
University of Nottingham
UK Crohn's Disease MAMS Trial Development
01.12.2026 $139,307.00 Crohn's Disease, Therapeutics
Children's Hospital Corporation
A sustainable gut single-cell atlas to advance understanding and treatment of Crohn's disease.
01.12.2026 $643,491.00 Crohn's Disease, Disease Biology
Children's Hospital Corporation
IL23R-Base-Edited Autologous HSC Therapy for Refractory Crohn's Disease
01.12.2026 $1,980,000.00 Crohn's Disease, Therapeutics
Mass General Brigham for the Massachusetts General Hospital
Crohn's and Ulcerative colitis: Results for older adults
12.03.2025 $861,492.00 Crohn's Disease, Disease Management
Regents of The University of Michigan
The SYMPTOM Trials: Scalable, community-based methods for persistent IBS-like symptoms in Crohn's Disease in remission.
11.19.2025 $2,498,429.00 Crohn's Disease, Therapeutics
The Regents of the University of Colorado, Denver
Identifying Facilitators and Barriers to Close Disease Activity Monitoring in Treat-to-Target care in Crohn's Disease.
11.19.2025 $1,269,877.00 Crohn's Disease, Disease Management
Children's Hospital Corporation
Identifying Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease-(Boston Studies)
11.05.2025 $2,261,115.00 Crohn's Disease, Prevention
Cedars-Sinai Medical Center
Integrative Multi-Omic and Computational Characterization to Identify Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease and Across IBD Populations
11.05.2025 $222,750.00 Crohn's Disease, Prevention
Care-for-Rare America Inc
Mechanism-Based Patient Stratification and Therapeutic Target Discovery - Munich VEOIBD Program
11.05.2025 $1,791,671.00 Crohn's Disease, Prevention
Children's Hospital Medical Center
Towards an Improved Understanding of Stricturing Pediatric Small Bowel Crohn's Disease and a Standardized Definition
11.05.2025 $2,072,212.00 Crohn's Disease, Diagnostics
Katholieke Universiteit te Leuven
Reprogramming epithelial plasticity and inflammatory architecture in pCD fistula (REPAIR-CD)
11.05.2025 $2,602,379.00 Crohn's Disease, Disease Biology
The Hospital for Sick Children
Identifying Molecular Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease (Toronto Studies)
10.21.2025 $1,642,365.00 Crohn's Disease, Prevention
Sage Bionetworks
Enabling FAIR Data Governance and Coordination to Enhance Mechanistic Origins and Clinical Impact Discovery in VEOIBD
10.21.2025 $222,750.00 Crohn's Disease, Prevention
Icahn School Of Medicine At Mount Sinai
Disease Mechanisms and Therapeutic Targets in Very Early Onset Inflammatory Bowel Disease: multiomic insights leveraging diverse populations and myeloid-stromal cross-talk
10.21.2025 $594,000.00 Crohn's Disease, Prevention
The Cleveland Clinic Foundation
Radiomics-based machine learning for stratification of Crohn's disease strictures on magnetic resonance enterography
10.21.2025 $2,725,254.00 Crohn's Disease, Diagnostics
Mass General Brigham for the Brigham and Women's Hospital, Inc.
Mechanisms of fibroblast inflammatory and fibrogenic transitions in Crohn's disease
10.21.2025 $1,505,189.00 Crohn's Disease, Disease Biology
Van Andel Research Institute
Epigenetic Mechanisms in Crohn's Disease
10.06.2025 $1,884,738.00 Crohn's Disease, Disease Biology
Washington University
Improving the Precision of Management in Perianal Crohn's Disease through Radiomics
10.06.2025 $3,191,332.00 Crohn's Disease, Diagnostics
You can filter rows:
Prev 12...15 Next
1 - 20 of 287 results